Indraprastha Medical Beheer
Beheer criteriumcontroles 4/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Shivakumar Pattabhiraman
Algemeen directeur
₹26.3m
Totale compensatie
| Percentage CEO-salaris | 96.0% |
| Dienstverband CEO | 5yrs |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 5yrs |
| Gemiddelde ambtstermijn bestuur | 5yrs |
Recente managementupdates
We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned
Sep 18
We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair
Sep 15Recent updates
Calculating The Fair Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Oct 14We Take A Look At Why Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Is Well Earned
Sep 18Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 30Indraprastha Medical's (NSE:INDRAMEDCO) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 11Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Soars 34% But It's A Story Of Risk Vs Reward
Aug 08Investors Should Be Encouraged By Indraprastha Medical's (NSE:INDRAMEDCO) Returns On Capital
Jun 12Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO) Shares Fly 42% But Investors Aren't Buying For Growth
Apr 06Why Investors Shouldn't Be Surprised By Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) Low P/E
Feb 01Why The 29% Return On Capital At Indraprastha Medical (NSE:INDRAMEDCO) Should Have Your Attention
Nov 03We Think Indraprastha Medical Corporation Limited's (NSE:INDRAMEDCO) CEO Compensation Looks Fair
Sep 15Indraprastha Medical's (NSE:INDRAMEDCO) Dividend Will Be Increased To ₹3.00
Sep 10Indraprastha Medical's (NSE:INDRAMEDCO) Upcoming Dividend Will Be Larger Than Last Year's
Aug 27Indraprastha Medical (NSE:INDRAMEDCO) Is Paying Out A Larger Dividend Than Last Year
Aug 08Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
Jul 31Indraprastha Medical (NSE:INDRAMEDCO) Is Very Good At Capital Allocation
Jan 21We Think Indraprastha Medical's (NSE:INDRAMEDCO) Profit Is Only A Baseline For What They Can Achieve
Nov 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Nov 02Why We Like The Returns At Indraprastha Medical (NSE:INDRAMEDCO)
May 12Estimating The Intrinsic Value Of Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
Jun 10Introducing Indraprastha Medical (NSE:INDRAMEDCO), A Stock That Climbed 24% In The Last Year
Feb 21Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹1b |
| Jun 30 2024 | n/a | n/a | ₹1b |
| Mar 31 2024 | ₹26m | ₹25m | ₹1b |
| Dec 31 2023 | n/a | n/a | ₹1b |
| Sep 30 2023 | n/a | n/a | ₹1b |
| Jun 30 2023 | n/a | n/a | ₹964m |
| Mar 31 2023 | ₹24m | ₹23m | ₹862m |
| Dec 31 2022 | n/a | n/a | ₹815m |
| Sep 30 2022 | n/a | n/a | ₹765m |
| Jun 30 2022 | n/a | n/a | ₹635m |
| Mar 31 2022 | ₹26m | ₹26m | ₹586m |
| Dec 31 2021 | n/a | n/a | ₹585m |
| Sep 30 2021 | n/a | n/a | ₹546m |
| Jun 30 2021 | n/a | n/a | ₹430m |
| Mar 31 2021 | ₹12m | ₹11m | ₹23m |
| Dec 31 2020 | n/a | n/a | -₹63m |
| Sep 30 2020 | n/a | n/a | -₹76m |
| Jun 30 2020 | n/a | n/a | ₹99m |
| Mar 31 2020 | ₹25m | ₹10m | ₹436m |
Compensatie versus markt: De totale vergoeding ($USD 311.67K ) Shivakumar } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 254.28K ).
Compensatie versus inkomsten: De vergoeding van Shivakumar is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Shivakumar Pattabhiraman (58 yo)
5yrs
Tenure
₹26,294,567
Compensatie
Mr. Shivakumar Pattabhiraman, B Com ACA Grad., CWA, serves as Managing Director and Additional Director of Indraprastha Medical Corporation Limited since November 5, 2019. He served as a Chief Financial an...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Additional Director | 5yrs | ₹26.29m | geen gegevens | |
| Chief Financial Officer | 6.4yrs | ₹15.20m | geen gegevens | |
| Company Secretary & Compliance Officer | 4.3yrs | ₹9.00m | geen gegevens |
5.0yrs
Gemiddelde duur
Ervaren management: Het managementteam van INDRAMEDCO is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| MD & Additional Director | 5yrs | ₹26.29m | geen gegevens | |
| Independent Non-Executive Director | 10yrs | ₹2.03m | 0% ₹ 0 | |
| Independent Non-Executive Director | 8.6yrs | ₹1.95m | geen gegevens | |
| Non-Executive Vice Chairman | no data | ₹1.43m | 0.26% ₹ 109.5m | |
| Independent Director | 5.3yrs | ₹1.43m | geen gegevens | |
| Non-Executive Director | 4.3yrs | ₹1.73m | 0.011% ₹ 4.6m | |
| Non-Executive Director | 19.3yrs | ₹1.95m | 0.15% ₹ 63.8m | |
| Independent Non-Executive Director | 3.8yrs | ₹1.35m | geen gegevens | |
| Non-Executive Director | 3.8yrs | ₹1.65m | geen gegevens | |
| Independent Director | 9.5yrs | ₹1.80m | geen gegevens | |
| Independent Non-Executive Woman Director | 4.5yrs | ₹1.58m | geen gegevens | |
| Director | less than a year | geen gegevens | geen gegevens |
5.0yrs
Gemiddelde duur
65yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van INDRAMEDCO wordt beschouwd als ervaren (gemiddelde ambtstermijn 5 jaar).